Skip to content

Clinical trials

Central Nervous System Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Belgium Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20142
20151
20161
20173
20181
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Completed6
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
University Hospital of Mont-Godinne2
Xenon Pharmaceuticals Inc.2
BBB-Therapeutics B.V.1
Eli Lilly and Company1
Géraldine Martens1
Integra LifeSciences Corporation1
Novartis1
Novartis Pharmaceuticals1
PXL University College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases16
Brain Diseases12
Nervous System Diseases10
Alzheimer Disease3
Neurocognitive Disorders3
Neurologic Manifestations3
Stroke3
Brain Neoplasms2
Breast Neoplasms2
Cardiovascular Diseases2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.